Foundation Fund Honors Local Giant in Cancer Research

His lab results set off worldwide speculation that he would be the man to cure cancer. But Columbus-born Judah Folkman was uneasy with the accolades because cancer is such a complex disease. Modest about his cancer research and extrapolating the results of his research on mice to humans, he said at the height of the angiogenesis media frenzy in 1998, “If you have cancer and you are a mouse, we can take good care of you.” The Judah Folkman Fund is just one of a thousand funds managed by the Columbus Jewish Foundation.

Dr. Folkman, with some members of his laboratory in 1997 (l to r):  Dr. Robert D’Amato, MD, PhD (discovered that thalidomide is an angiogenesis inhibitor), Dr. Micchael O’Reilly, MD (discovered angiostatin and endostatin), and Dr. Donald Ingber, MD, PhD (discovered the angiogenesis inhibitor, TNP-470).

Leave a reply